Brokerages Set CRISPR Therapeutics AG (NASDAQ:CRSP) Target Price at $74.50
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-two ...
Zacks.com on MSN19h
CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?
The rise in CRISPR Therapeutics' share price can be attributed to the better-than-expected Q4 results and a rating upgrade by a well-established financial services firm.
Citi Sticks to Their Buy Rating for Crispr Therapeutics AG (CRSP)
Citi analyst Yigal Nochomovitz maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today and set a price target of ...
Crispr Therapeutics price target lowered to $82 from $89 at Citi
Citi analyst Yigal Nochomovitz lowered the firm’s price target on Crispr Therapeutics (CRSP) to $82 from $89 and keeps a Buy rating on the ...
kalkinemedia17h
How Is CRISPR Therapeutics (NASDAQ:CRSP) Expanding Its Market Presence
Highlights,CRISPR Therapeutics has seen price adjustments from financial firms, reflecting shifts in market expectations.,The ...
ENDPOINTS NEWS1h
Ex­clu­sive: CRISPR de­liv­ery start­up, based on UC Berke­ley and UCSF sci­ence, shuts down
Spot­light Ther­a­peu­tics, a start­up with a bold vi­sion for de­liv­er­ing CRISPR ther­a­pies in­to the body with­out the ...
This Bath & Body Works Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
JP Morgan analyst Matthew Boss upgraded the rating for Bath & Body Works, Inc. BBWI from Neutral to Overweight and boosted ...
BJ’s Wholesale Club Holdings, Inc. (NYSE:BJ) Receives $94.88 Average Price Target from Brokerages
BJ’s Wholesale Club Holdings, Inc. (NYSE:BJ – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seventeen brokerages that are currently covering the company, Marketbeat ...